COVID-19 herd immunity will take time, easier to achieve with vaccine, says WHO’s Soumya Swaminathan
The chief scientist at the global health body said that more waves of coronavirus would be required to get to a stage of natural immunity
London: The chief scientist of the WHO, Dr Soumya Swaminathan, on Friday warned that the concept of “herd immunity”, or a large section of the population developing antibodies against COVID-19, is still a long way off and can be sped up by a vaccine.
In a social media live event organised by the World Health Organisation from Geneva on Friday, the scientist said that more waves of the infection would be required to get to a stage of natural immunity. Therefore, she warned, that at least for the next year or so, the world needs to be “geared up” to do everything possible to keep the novel coronavirus at bay while scientists work on vaccines. Meanwhile, therapeutics will help keep death rates low and allow people to get on with their lives.
“For this concept of herd immunity, you need 50 to 60 percent of the population to have this immunity to be actually able to break those chains of transmission,” explained Swaminathan.
“That’s much easier to do with a vaccine; we can achieve it faster and without people getting sick and dying. So, it is much better to do it that way, to achieve herd immunity through natural infection. We would have several waves [of infection] and unfortunately also the mortality that we see,” she said.
She added, “Over a period of time, people will start developing natural immunity. We know now from the studies that have been done in many of the affected countries that usually between 5 to 10 percent of the population has developed antibodies. In some places it’s been higher than that, up to 20 percent.
“As there are waves of this infection going through countries, people are going to develop antibodies and those people will be hopefully immune for some time and so they will also act as barriers and brakes to the spread of this infection,” Swaminathan, a pediatrician from India and a globally recognised researcher on tuberculosis and HIV, said.
The scientist, who was addressing a range of questions on coronavirus vaccines and therapeutics, said that for the foreseeable future it is important to be focussed on doing the "right thing" such as public health measures that are known to work while the world waits for a vaccine.
“Even if the clinical trials are successful and we have a couple of vaccines by the end of this year, we still need the hundreds of billions of doses, which will take time,” she said.
Elaborating on vaccine development, the chief scientist said there are over 200 candidates in some stage of development as she highlighted the extraordinary speed at which the science has been moving around the understanding of the novel coronavirus.
“Vaccine development is normally quite a lengthy and laborious process… the more candidates we have, the more opportunities we have for success,” she said.
“Most people who recover from COVID-19 develop neutralising antibodies, which means a vaccine has a good chance of offering protective immunity,” she said.
Asked about the fearful prospect of never getting a vaccine for COVID-19, Dr Swaminathan admitted that we have to entertain the possibility that we may have to “learn to live with this virus”.
“Right now it seems frightening; what will we do if we don’t have a vaccine? But it is a possibility, there is no 100 percent guarantee that we will have one. Let’s hope we do. But we know, now, what are the measures that we can take to minimise the spread of this infection, such as maintaining distance, hand washing, respiratory hygiene and wearing of masks,” she said.
The coronavirus has so far claimed over 6.3 lakh lives with more than 15.5 million confirmed cases across the world, according to Johns Hopkins University COVID-19 tracker.
The active cases comprise 0.10 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.71 per cent.
A wide range of symptoms, including brain fog, fatigue, coughing, and shortness of breath, are associated with long COVID and may be caused by harm to or dysfunction of various organ systems. Read more.
A significant amount of vision loss usually precedes the onset of glaucoma symptoms